Literature DB >> 29101913

Study Break: Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?

Mona Salimi1.   

Abstract

Entities:  

Year:  2017        PMID： 29101913      PMCID： PMC5786661     

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN： 1028-852X


× No keyword cloud information.
  2 in total

Review 1.  Investigational Drug Treatments for Triple-Negative Breast Cancer.

Authors:  Christos Damaskos; Nikolaos Garmpis; Anna Garmpi; Konstantinos Nikolettos; Panagiotis Sarantis; Vasiliki E Georgakopoulou; Afroditi Nonni; Dimitrios Schizas; Efstathios A Antoniou; Michalis V Karamouzis; Nikos Nikolettos; Konstantinos Kontzoglou; Alexandros Patsouras; Errika Voutyritsa; Athanasios Syllaios; Evangelos Koustas; Nikolaos Trakas; Dimitrios Dimitroulis
Journal:  J Pers Med       Date:  2021-07-10

2.  Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.

Authors:  Nehal Gupta; Shreyas Gaikwad; Itishree Kaushik; Stephen E Wright; Maciej M Markiewski; Sanjay K Srivastava
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.